Re: Farmas USA
Join Biotech Analysis Central and invest alongside Terry Chrisomalis
I chose to launch this service because there is a need for both traders and investors to understand the logic behind investing in a biotech stock. Most of these stocks trade accordingly by momentum. There can be gains made from knowing about other items in these biotech stocks. Such gains can be made from knowing about upcoming catalysts, potential trial results, and any other type of news event. I want to educate subscribers on what is the best approach when attempting to invest in this sector. Under my service, everyone will learn the ins/and outs of biotech investing. My goal is to prune everyone to better understand this sector and what is necessary to succeed in it.
Promotion Price (Exclusive Special)
We have reached past the 25 subscribers mark for the Biotech Analysis Central SA marketplace. As a Christmas special we are extending the lower legacy rate of $35 per month or $350 per year for the next 2 weeks only until Jan 1, 2018. At which time the rate shall increase to $49 per month or $490 per year. We encourage you to take advantage of this discount now before the rate increases starting the new year. As always there will be a 2-week free trial period to see if Biotech Analysis Central is right for you.
